VTGN
VTGN
NASDAQ · Biotechnology

Vistagen Therapeutics Inc

$0.56
+0.06 (+11.52%)
As of Feb 8, 2:24 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 9.99M 9.03M 9.73M
Net Income 2.33M 1.99M 2.35M
EPS
Profit Margin 23.4% 22.0% 24.2%
Rev Growth +15.3% +1.4% +15.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 9.04M 10.09M 8.64M
Total Equity 17.11M 16.52M 14.60M
D/E Ratio 0.53 0.61 0.59
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 3.37M 3.04M 3.38M
Free Cash Flow 2.45M 1.40M 2.01M